Systemic Sclerosis: Commonly Asked Questions by Rheumatologists

Overview

Journal J Clin Rheumatol

Date 2015 Mar 26

PMID 25807095

Citations 11

Authors

Amber Young

Dinesh Khanna

Affiliations

Soon will be listed here.

Citing Articles

Cardiac Morpho-Functional Changes, Inflammation and Fibrosis in Systemic Sclerosis-A Pilot Study of a Tertiary Center Cohort.

Dorniak K, Gogulska Z, Viti A, Glinska A, Kulawiak-Galaska D, Fijalkowska J Diagnostics (Basel). 2025; 15(3).

PMID: 39941322 PMC: 11817609. DOI: 10.3390/diagnostics15030393.

Economic and Health Care Resource Use Burden of Systemic Sclerosis.

Khanna D, Furst D, Li J, Meng Q, Yuan Y, Lesperance T ACR Open Rheumatol. 2023; 5(12):677-684.

PMID: 37794717 PMC: 10716802. DOI: 10.1002/acr2.11616.

Metabolic fingerprinting of systemic sclerosis: a systematic review.

Morales-Gonzalez V, Galeano-Sanchez D, Covaleda-Vargas J, Rodriguez Y, Monsalve D, Pardo-Rodriguez D Front Mol Biosci. 2023; 10:1215039.

PMID: 37614441 PMC: 10442829. DOI: 10.3389/fmolb.2023.1215039.

Systemic Sclerosis and the Liver.

Green E, Kahl L, Jou J Clin Liver Dis (Hoboken). 2021; 18(2):76-80.

PMID: 34584672 PMC: 8450479. DOI: 10.1002/cld.1074.

Poor maternal and foetal outcomes in women with systemic sclerosis: an interview-based study at a tertiary centre.

Kharbanda R, Naveen R, Misra D, Gupta L, Agarwal V Rheumatol Int. 2021; 41(6):1133-1142.

PMID: 33682026 DOI: 10.1007/s00296-021-04793-8.

References

Sallam H, McNearney T, Chen J . Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006; 23(6):691-712. DOI: 10.1111/j.1365-2036.2006.02804.x. View

Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L . EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009; 68(5):620-8. DOI: 10.1136/ard.2008.096677. View

Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger Jr T . Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum. 1994; 37(6):902-6. DOI: 10.1002/art.1780370619. View

Nihtyanova S, Schreiber B, Ong V, Rosenberg D, Moinzadeh P, Coghlan J . Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol. 2014; 66(6):1625-35. DOI: 10.1002/art.38390. View

Domsic R, Fasanella K, Bielefeldt K . Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2007; 53(5):1163-74. DOI: 10.1007/s10620-007-0018-8. View

Walker J, Pope J, Baron M, LeClercq S, Hudson M, Taillefer S . The development of systemic sclerosis classification criteria. Clin Rheumatol. 2007; 26(9):1401-9. DOI: 10.1007/s10067-007-0537-x. View

Nagaraja V, Denton C, Khanna D . Old medications and new targeted therapies in systemic sclerosis. Rheumatology (Oxford). 2014; 54(11):1944-53. PMC: 4603276. DOI: 10.1093/rheumatology/keu285. View

Rose S, Young M, Reynolds J . Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am. 1999; 27(3):563-94. DOI: 10.1016/s0889-8553(05)70021-2. View

Omair M, Phumethum V, Johnson S . Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis. Clin Exp Rheumatol. 2012; 30(2 Suppl 71):S55-9. View

10.

Forbes A, Marie I . Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford). 2009; 48 Suppl 3:iii36-9. DOI: 10.1093/rheumatology/ken485. View

11.

Chung L, Chen H, Khanna D, Steen V . Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire. Arthritis Care Res (Hoboken). 2012; 65(3):454-63. DOI: 10.1002/acr.21827. View

12.

Shanmugam V, Swistowski D, Saddic N, Wang H, Steen V . Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis. Clin Rheumatol. 2011; 30(10):1363-8. PMC: 3664239. DOI: 10.1007/s10067-011-1766-6. View

13.

Lidar M, Langevitz P . Pregnancy issues in scleroderma. Autoimmun Rev. 2011; 11(6-7):A515-9. DOI: 10.1016/j.autrev.2011.11.021. View

14.

Phumethum V, Jamal S, Johnson S . Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol. 2010; 38(2):289-96. DOI: 10.3899/jrheum.100361. View

15.

Lonzetti L, Joyal F, Raynauld J, Roussin A, Goulet J, Rich E . Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001; 44(3):735-6. DOI: 10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F. View

16.

Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D . Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011; 63(11):3522-30. DOI: 10.1002/art.30541. View

17.

Penn H, Howie A, Kingdon E, Bunn C, Stratton R, Black C . Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM. 2007; 100(8):485-94. DOI: 10.1093/qjmed/hcm052. View

18.

Steen V . Pregnancy in scleroderma. Rheum Dis Clin North Am. 2007; 33(2):345-58, vii. DOI: 10.1016/j.rdc.2007.03.001. View

19.

Daoussis D, Liossis S, Tsamandas A, Kalogeropoulou C, Kazantzi A, Sirinian C . Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford). 2009; 49(2):271-80. PMC: 2806066. DOI: 10.1093/rheumatology/kep093. View

20.

de Paula D, Klem F, Lorencetti P, Muller C, Azevedo V . Rituximab-induced regression of CREST-related calcinosis. Clin Rheumatol. 2012; 32(2):281-3. DOI: 10.1007/s10067-012-2124-z. View